真木 晋太郎

Tadalafil for Treatment of Fetal Growth Restriction: A Review of Experimental and Clinical Studies. 

Biomedicines 12(4) 2024年4月4日  査読有り筆頭著者責任著者

Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction. 

Medicina (Kaunas, Lithuania) 59(5) 2023年5月8日  査読有り責任著者

Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb). 

BMJ open 12(6) e054925 2022年6月14日  査読有り

Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial. 

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 34(22) 3709-3715 2021年11月  査読有り

Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction. 

Journal of clinical medicine 9(5) 2020年5月13日  査読有り筆頭著者責任著者

Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial. 

Journal of clinical medicine 8(6) 2019年6月15日  査読有り筆頭著者責任著者

Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions. 

Scientific reports 9(1) 234-234 2019年1月18日  査読有り

TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial. 

BMJ open 8(10) e020948 2018年10月30日  責任著者

Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice. 

American journal of hypertension 31(1) 89-96 2017年12月8日  査読有り